View Older Stories View More Recent Stories

Apr 18, 2026 10:00PM Q1 MedTech quarterly preview: BTIG

Apr 15, 2026 10:00AM Boston Scientific (BSX) PT Lowered to $90 at Truist

Apr 6, 2026 07:44AM Piper Sandler on BSX and MDT Following KOL Call

Apr 2, 2026 08:06AM RBC Capital on Boston Scientific (BSX): 'We Are Bullish on the LT Thesis At Current Valuations'

Mar 31, 2026 09:40AM UBS Reiterates Buy Rating on Boston Scientific (BSX)

Mar 31, 2026 05:44AM Boston Scientific (BSX) call put ratio 1.3 calls to 1 put as share price down 9%

Mar 30, 2026 10:33AM Raymond James downgrades Boston Scientific but long-term story remains intact

Mar 30, 2026 09:13AM Truist Securities Reiterates Buy Rating on Boston Scientific (BSX)

Mar 30, 2026 08:56AM RBC Capital on Boston Scientific (BSX): 'Results Point to Positive Uptake'

Mar 30, 2026 07:34AM Boston Scientific (BSX) Reiterated at Buy by Stifel After CHAMPION-AF Read-Out

Mar 30, 2026 06:45AM Boston Scientific receives FDA clearance for Asurys fluid management device

Mar 30, 2026 03:42AM Raymond James Downgrades Boston Scientific (BSX) to Outperform

Mar 27, 2026 08:21AM Bernstein Reiterates Outperform Rating on Boston Scientific (BSX)

Mar 24, 2026 06:14AM Evercore ISI adds Boston Scientific (BSX) to TAP Outperform List

Mar 24, 2026 05:26AM Stifel on Boston Scientific (BSX): 'this review adds to our optimism'

Mar 18, 2026 09:34AM Boston Scientific (BSX) PT Lowered to $92 at Truist Securities

Mar 16, 2026 04:25PM Jefferies on Boston Scientific (BSX): ICTx segment emerges as a double-digit growth engine

Mar 10, 2026 08:35AM Piper Sandler's Key Takeaways From CRT 2026

Mar 9, 2026 08:18AM Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'

Mar 4, 2026 08:37AM TD Cowen on Boston Scientific (BSX): 'We See a Valuation Disconnect at Current Prices'

Feb 6, 2026 09:30AM Boston Scientific (BSX) PT Lowered to $112 at Bernstein SocGen Group

Feb 6, 2026 08:30AM Evercore ISI Removes Boston Scientific (BSX) from TAP List

Feb 5, 2026 08:53AM Boston Scientific (BSX) PT Lowered to $115 but RBC Capital Sees Stock Reaction as a Buying Opportunity

Feb 5, 2026 07:13AM Boston Scientific (BSX) PT Lowered to $97 at Needham

Feb 5, 2026 06:20AM Oppenheimer Reiterates Outperform Rating on Boston Scientific (BSX)

Feb 5, 2026 05:56AM Boston Scientific (BSX) PT Lowered to $95 at Truist Securities

Feb 5, 2026 05:49AM Boston Scientific (BSX) PT Lowered to $112 at Canaccord Genuity

Feb 4, 2026 04:05PM Boston Scientific (BSX) PT Lowered to $110 at Stifel

Feb 4, 2026 03:01PM Boston Scientific (BSX) PT Lowered to $110 at BTIG

Feb 4, 2026 09:52AM Boston Scientific (BSX) PT Lowered to $105 at Piper Sandler, 'Buy The Dip'

Feb 4, 2026 06:31AM Boston Scientific (BSX) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance

Feb 2, 2026 09:41AM TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)

Jan 26, 2026 06:05AM Evercore ISI Adds Boston Scientific (BSX) to TAP List

Jan 20, 2026 11:36AM Mizuho on Boston Scientific (BSX): 'we do not foresee any FTC risk concerns'

Jan 16, 2026 09:22AM Truist on Boston Scientific (BSX): 'PEN Acquisition To Strengthen BSX's Path Fwd'

Jan 16, 2026 08:50AM Jefferies Downgrades Penumbra (PEN) to Hold

Jan 15, 2026 01:08PM Needham Reiterates Buy Rating on Boston Scientific (BSX)

Jan 15, 2026 11:37AM Wells Fargo Downgrades Penumbra (PEN) to Equal Weight

Jan 15, 2026 09:54AM Morgan Stanley on Boston Scientific (BSX): 'Stock is looking too cheap and has clear catalysts'

Jan 15, 2026 09:53AM Stifel on Boston Scientific (BSX): 'Compelling PEN Deal Adds to Growth and Future Margin Expansion'

Jan 15, 2026 09:30AM William Blair Downgrades Penumbra (PEN) to Market Perform

Jan 15, 2026 08:16AM Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down

Jan 14, 2026 04:25AM Boston Scientific (BSX) Removed from Citi Focus List

Jan 9, 2026 07:33AM Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'

Jan 5, 2026 11:00PM BofA’s six MedTech picks for 2026 on strong earnings growth

Dec 17, 2025 09:12AM UBS on Boston Scientific (BSX): Risk/Reward Into 2026 Skewed to the Upside

Dec 11, 2025 10:09AM TD Cowen on Boston Scientific (BSX): 'We See Sustained Momentum Driving Multiple Re-Expansion'

Dec 8, 2025 04:16PM Raymond James Publishes 31st Annual Analyst Best Picks List for 2026

Dec 8, 2025 07:42AM Nephron Downgrades Boston Scientific (BSX) to Hold

Nov 21, 2025 02:15AM These 2 MedTech companies can continue to gain EP share in 2026: BofA

View More Recent Stories View Older Stories